Ottawa, Aug 20 (IANS) Canada’s drug regulator announced it has authorised Pfizer-BioNTech Comirnaty Covid-19 vaccine for use as a booster dose in children aged 5 to 11 years.
Health Canada said this booster dose provides a great option to restore protection for this age group, especially for those who are at high risk of severe illness, reports Xinhua news agency.
Meanwhile the National Advisory Committee on Immunization (NACI) released national guidance for its use on Friday.
NACI recommended that children 5 to 11 years of age who have an underlying medical condition that places them at high risk of severe illness due to Covid-19, including kids who are immunocompromised, should be offered a first booster dose of the 10 mcg vaccine at least six months after completion of a primary series.
For all other children in this age group, NACI recommended the 10 mcg Comirnaty vaccine may be offered as a first booster at least six months after completion of a primary series in the context of heightened epidemiological risk.
Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.